lobbying_filings_raw: e062ffc0-e953-4665-bf4e-8716ddbfb040
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| e062ffc0-e953-4665-bf4e-8716ddbfb040 | Q3 | 15042 | FOLEY & LARDNER LLP | 120768 | NOVOCURE INC. | 2020 | third_quarter | 2020-10-18T22:44:57.873000-04:00 | 100000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/e062ffc0-e953-4665-bf4e-8716ddbfb040/", "filing_uuid": "e062ffc0-e953-4665-bf4e-8716ddbfb040", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2020, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/e062ffc0-e953-4665-bf4e-8716ddbfb040/print/", "filing_document_content_type": "text/html", "income": "100000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Theodore Bornstein", "dt_posted": "2020-10-18T22:44:57.873000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "3000 K Street NW", "registrant_address_2": "Suite 600", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20007", "registrant": {"id": 15042, "url": "https://lda.senate.gov/api/v1/registrants/15042/", "house_registrant_id": 33563, "name": "FOLEY & LARDNER LLP", "description": "law firm", "address_1": "3000 K Street NW", "address_2": "Suite 600", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20007", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "JARED B. RIFIS", "contact_telephone": "+1 202-295-4154", "dt_updated": "2026-01-30T13:33:06.842869-05:00"}, "client": {"id": 120768, "url": "https://lda.senate.gov/api/v1/clients/120768/", "client_id": 1005445, "name": "NOVOCURE INC.", "general_description": "Commercial stage oncology dedicated to advancement of TTF therapy to treat solid tumors", "client_government_entity": false, "client_self_select": null, "state": "NH", "state_display": "New Hampshire", "country": "US", "country_display": "United States of America", "ppb_state": "NH", "ppb_state_display": "New Hampshire", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2017-10-10"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "â\u20ac\u2039Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, and before the Department of Health and Human Services, sub-agencies, and staffs to each, with respect to coverage and pricing issues; review relevant statutes and regulations regarding same.", "foreign_entity_issues": "Novocure Limited, identified on Form LD-1, owns 100% of Novocure, Inc.", "lobbyists": [{"lobbyist": {"id": 67114, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CROSSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MAN", "general_issue_code_display": "Manufacturing", "description": "Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, and before the Department of Health and Human Services, sub-agencies, and staffs to each, with respect to coverage and pricing issues; review relevant statutes and regulations regarding same.", "foreign_entity_issues": "Novocure Limited, identified on Form LD-1, owns 100% of Novocure, Inc.", "lobbyists": [{"lobbyist": {"id": 67114, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CROSSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "VET", "general_issue_code_display": "Veterans", "description": "Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, and before the Department of Health and Human Services, sub-agencies, and staffs to each, with respect to coverage and pricing issues; review relevant statutes and regulations regarding same.", "foreign_entity_issues": "Novocure Limited, identified on Form LD-1, owns 100% of Novocure, Inc.", "lobbyists": [{"lobbyist": {"id": 67114, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CROSSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, and before the Department of Health and Human Services, sub-agencies, and staffs to each, with respect to coverage and pricing issues; review relevant statutes and regulations regarding same.", "foreign_entity_issues": "Novocure Limited, identified on Form LD-1, owns 100% of Novocure, Inc.", "lobbyists": [{"lobbyist": {"id": 67114, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CROSSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "â\u20ac\u2039Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, and before the Department of Health and Human Services, sub-agencies, and staffs to each, with respect to coverage and pricing issues; review relevant statutes and regulations regarding same.", "foreign_entity_issues": "Novocure Limited, identified on Form LD-1, owns 100% of Novocure, Inc.", "lobbyists": [{"lobbyist": {"id": 67114, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CROSSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, and before the Department of Health and Human Services, sub-agencies, and staffs to each, with respect to coverage and pricing issues; review relevant statutes and regulations regarding same.", "foreign_entity_issues": "Novocure Limited, identified on Form LD-1, owns 100% of Novocure, Inc.", "lobbyists": [{"lobbyist": {"id": 67114, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CROSSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "INS", "general_issue_code_display": "Insurance", "description": "Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, and before the Department of Health and Human Services, sub-agencies, and staffs to each, with respect to coverage and pricing issues; review relevant statutes and regulations regarding same.", "foreign_entity_issues": "Novocure Limited, identified on Form LD-1, owns 100% of Novocure, Inc.", "lobbyists": [{"lobbyist": {"id": 67114, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CROSSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, and before the Department of Health and Human Services, sub-agencies, and staffs to each, with respect to coverage and pricing issues; review relevant statutes and regulations regarding same.", "foreign_entity_issues": "Novocure Limited, identified on Form LD-1, owns 100% of Novocure, Inc.", "lobbyists": [{"lobbyist": {"id": 67114, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CROSSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "SCI", "general_issue_code_display": "Science/Technology", "description": "Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, and before the Department of Health and Human Services, sub-agencies, and staffs to each, with respect to coverage and pricing issues; review relevant statutes and regulations regarding same.", "foreign_entity_issues": "Novocure Limited, identified on Form LD-1, owns 100% of Novocure, Inc.", "lobbyists": [{"lobbyist": {"id": 67114, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CROSSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |